Ardent Health (NYSE:ARDT - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.18 by $0.10, Zacks reports. Ardent Health had a net margin of 2.15% and a return on equity of 14.30%. Ardent Health updated its FY 2026 guidance to 0.900-1.270 EPS.
Ardent Health Price Performance
Shares of ARDT stock traded up $0.15 during midday trading on Tuesday, reaching $10.13. 492,301 shares of the company were exchanged, compared to its average volume of 393,366. The company's 50 day moving average price is $9.25 and its two-hundred day moving average price is $9.85. The company has a market cap of $1.45 billion, a P/E ratio of 10.55 and a beta of 0.93. Ardent Health has a 12 month low of $8.07 and a 12 month high of $15.48. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.85 and a current ratio of 1.97.
Wall Street Analyst Weigh In
Several research firms have weighed in on ARDT. Zacks Research upgraded shares of Ardent Health from a "strong sell" rating to a "hold" rating in a research note on Wednesday, March 25th. Leerink Partners decreased their price target on shares of Ardent Health from $16.00 to $15.00 and set an "outperform" rating for the company in a report on Friday, March 6th. Royal Bank Of Canada lowered their price objective on shares of Ardent Health from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Monday, March 9th. Finally, JPMorgan Chase & Co. cut their target price on shares of Ardent Health from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, January 20th. Seven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Ardent Health presently has an average rating of "Hold" and an average target price of $14.25.
Check Out Our Latest Analysis on Ardent Health
Institutional Investors Weigh In On Ardent Health
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. VARCOV Co. acquired a new stake in Ardent Health in the 4th quarter valued at about $232,000. Wells Fargo & Company MN boosted its position in shares of Ardent Health by 29.1% in the fourth quarter. Wells Fargo & Company MN now owns 25,963 shares of the company's stock worth $229,000 after buying an additional 5,858 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Ardent Health in the 4th quarter valued at about $228,000. WINTON GROUP Ltd acquired a new position in Ardent Health in the 2nd quarter valued at approximately $228,000. Finally, Alliancebernstein L.P. raised its holdings in shares of Ardent Health by 24.8% during the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company's stock worth $218,000 after acquiring an additional 3,272 shares in the last quarter.
About Ardent Health
(
Get Free Report)
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.